VELOXIS PHARMACEUTICALS A/S: Financial statements 2026
CVR: 26527767
Source: annual report 2026, Danish Business Authority
01/04/2025 – 31/03/2026
VELOXIS PHARMACEUTICALS A/S (CVR 26527767) has filed annual accounts for 2026. In 2026, the company reported a net result of DKK -1,553,000. Equity in the 2026 report amounted to DKK 611,587,000. The solvency ratio was 99.8%. The company had 1 employee in the financial year.
- Profit/Loss
- DKK -1,553,000
- Equity
- DKK 611,587,000
- Total Assets
- DKK 612,939,000
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2026 | - | - | -1.6M | 611.6M | 1 |
| 2025 | - | - | - | 88.6M USD | 1 |
| 2024 | - | - | - | -10.5M USD | 1 |
| 2023 | - | - | - | 2.8M USD | 1 |
| 2022 | 0 USD | 0 USD | 2.1M USD | 2.9M USD | - |
Official annual report
Find more companies like VELOXIS PHARMACEUTICALS A/S
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorAbout VELOXIS PHARMACEUTICALS A/S
VELOXIS PHARMACEUTICALS A/S is a Danish company of the type Aktieselskab based in Nordhavn, founded in 2002. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named LIFECYCLE PHARMA A/S and PHAROTECH A/S. The management consists of Daisuke Matsuo. The board consists of Keigo Nakatsukasa (chair), Daisuke Matsuo and Kenro Yuzaki. The company is owned by Asahi Kasei Corporation. The company has 1 employee (2022). In 2026, the company reported a net result of DKK -1,553,000. Equity in the 2026 report amounted to DKK 611,587,000.
